Treating Comorbid Depression During Care Transitions Using Relational Agents

NACompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

May 21, 2017

Study Completion Date

May 21, 2017

Conditions
Chronic IllnessChronic PainDepressionComorbid Depression
Interventions
OTHER

Pre-Post Feasibility

The feasibility testing phase will include 25 subjects. Total duration of pre-post feasibility testing will be 6 weeks upon retrieval of the RA-CBT tablet and follow up questionnaires, quantitative exit interview, and/or an optional extended qualitative exit interview. The extended exit interview is a qualitative semi-formal interview focusing on gathering participant experiences working with the intervention, the barriers and facilitators encountered, as well as overall feedback for the pre-post feasibility study and the relational agent.

Trial Locations (1)

02118

Boston Medical Center, Boston

Sponsors
All Listed Sponsors
collaborator

Northeastern University

OTHER

lead

Boston Medical Center

OTHER